Self-amplifying RNA vaccines against antigenically distinct SARS-CoV-2 variants

Lancet Infect Dis. 2024 Apr;24(4):330-331. doi: 10.1016/S1473-3099(23)00734-X. Epub 2023 Dec 20.

Authors

Sander Herfst¹, Rory D de Vries²

Affiliations

¹ Department of Viroscience, Erasmus MC, 3015 GE Rotterdam, Netherlands.
² Department of Viroscience, Erasmus MC, 3015 GE Rotterdam, Netherlands. Electronic address: r.d.devries@erasmusmc.nl.

PMID: 38141631
DOI: 10.1016/S1473-3099(23)00734-X

No abstract available

MeSH terms

Antibodies, Neutralizing
Antibodies, Viral
COVID-19* / prevention & control
Humans
SARS-CoV-2 / genetics
mRNA Vaccines

Substances

mRNA Vaccines
Antibodies, Neutralizing
Antibodies, Viral

Supplementary concepts

SARS-CoV-2 variants